LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L, AZN) and Sanofi's Beyfortus (nirsevimab) has been approved in the European Union for the prevention of respiratory syncytial virus or RSV lower respiratory
AstraZeneca/Sanofi's Beyfortus receives EC approval for prevention of RSV in infants pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
GSK's application for its RSV vaccine accepted by EMA under accelerated assessment pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca/Sanofi's Beyfortus receives CHMP recommendation for prevention of RSV disease in infants pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.